AB1068 REGISTRY OF ANIFROLUMAB USE IN SYSTEMIC LUPUS ERYTHEMATOSUS IN THE VALENCIAN COMMUNITY
AB1068 REGISTRY OF ANIFROLUMAB USE IN SYSTEMIC LUPUS ERYTHEMATOSUS IN THE VALENCIAN COMMUNITY
About this item
Full title
Author / Creator
Publisher
Kidlington: BMJ Publishing Group Ltd and European League Against Rheumatism
Journal title
Language
English
Formats
Publication information
Publisher
Kidlington: BMJ Publishing Group Ltd and European League Against Rheumatism
Subjects
More information
Scope and Contents
Contents
Background:Anifrolumab is a recently approved human monoclonal antibody of the immunoglobulin G1 kappa type for the treatment of SLE (Systemic Lupus Erythematosus). There is limited real-world data available.Objectives:To describe the demographic characteristics, efficacy, and safety of Anifrolumab in patients with SLE in real-world setting.Methods...
Alternative Titles
Full title
AB1068 REGISTRY OF ANIFROLUMAB USE IN SYSTEMIC LUPUS ERYTHEMATOSUS IN THE VALENCIAN COMMUNITY
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_3068460495
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3068460495
Other Identifiers
ISSN
0003-4967
E-ISSN
1468-2060
DOI
10.1136/annrheumdis-2024-eular.5791
